Literature DB >> 19184288

Comparative evaluation of re-epithelialization promoted by fresh or cryopreserved cultured dermal substitute.

Naoto Yamada1, Eiju Uchinuma, Yasuhiro Matsumoto, Yoshimitsu Kuroyanagi.   

Abstract

Allogeneic cultured dermal substitute (CDS) was prepared by plating cultured fibroblasts on a two-layered spongy matrix of hyaluronic acid and atelocollagen, followed by culturing for 1 week. The resulting fresh CDS was then cryopreserved in a freezer at -152 degrees C in accordance with conventional procedures. Fresh CDS was rinsed thoroughly with lactated Ringer's solution to remove fetal bovine serum (FBS) and was then used in the clinical study, whereas cryopreserved CDS was thawed and then rinsed with lactated Ringer's solution to remove cryoprotectant and FBS. The present study was designed to compare the efficacy of fresh and cryopreserved CDS in promoting reepithelialization at donor sites leaving behind split-thickness skin autografts. Fourteen donor sites were used for this comparative study. There were no differences in the period of complete re-epithelialization between the fresh and cryopreserved CDS. The results of this comparative study thus suggest that cryopreserved CDS is able to maintain the same level of potency to promote re-epithelialization as fresh CDS. This indicates that, although the release of growth factors is suppressed to some extent during the course of cryopreserving, thawing, and rinsing procedures, it is still sufficient to promote re-epithelialization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19184288     DOI: 10.1007/s10047-008-0428-1

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  20 in total

1.  Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.

Authors:  M Tanaka; N Nakakita; Y Kuroyanagi
Journal:  J Biomater Sci Polym Ed       Date:  1999       Impact factor: 3.517

2.  Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.

Authors:  Naohiro Kashiwa; Osamu Ito; Takeshige Ueda; Kentaro Kubo; Hiromichi Matsui; Yoshimitsu Kuroyanagi
Journal:  Artif Organs       Date:  2004-05       Impact factor: 3.094

3.  An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.

Authors:  Toshio Hasegawa; Yasushi Suga; Masayuki Mizoguchi; Shigenori Muramatsu; Yuki Mizuno; Hideoki Ogawa; Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Dermatol       Date:  2005-09       Impact factor: 4.005

4.  Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.

Authors:  Masao Yonezawa; Hideaki Tanizaki; Naoko Inoguchi; Masahide Ishida; Mayumi Katoh; Takao Tachibana; Yoshiki Miyachi; Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Int J Dermatol       Date:  2007-01       Impact factor: 2.736

5.  A study of cytokines released from fibroblasts in cultured dermal substitute.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Artif Organs       Date:  2005-10       Impact factor: 3.094

6.  Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.

Authors:  Y Kuroyanagi; N Yamada; R Yamashita; E Uchinuma
Journal:  Artif Organs       Date:  2001-03       Impact factor: 3.094

7.  Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2003       Impact factor: 1.731

8.  Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.

Authors:  Yoichi Moroi; Shohei Fujita; Shuji Fukagawa; Toshihiko Mashino; Takako Goto; Teiichi Masuda; Kazunori Urabe; Kentaro Kubo; Hiromichi Matsui; Shizuko Kagawa; Yoshimitsu Kuroyanagi; Masutaka Furue
Journal:  Eur J Dermatol       Date:  2004 May-Jun       Impact factor: 3.328

9.  Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS).

Authors:  Toshio Ohtani; Katsuyuki Okamoto; Chikako Kaminaka; Tomoh Kishi; Mikihisa Sakurane; Yuki Yamamoto; Koji Uede; Kentaro Kubo; Yoshimitsu Kuroyanagi; Fukumi Furukawa
Journal:  Eur J Dermatol       Date:  2004 May-Jun       Impact factor: 3.328

10.  Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation.

Authors:  Kentaro Kubo; Yoshimitsu Kuroyanagi
Journal:  Artif Organs       Date:  2004-02       Impact factor: 3.094

View more
  8 in total

Review 1.  Journal of Artificial Organs 2008: the year in review.

Authors:  Y Sawa; E Tatsumi; A Funakubo; T Horiuchi; K Iwasaki; A Kishida; T Masuzawa; K Matsuda; M Nishimura; T Nishimura; Y Tomizawa; T Yamaoka; H Watanabe
Journal:  J Artif Organs       Date:  2009-03-29       Impact factor: 1.731

2.  A case of lower-extremity deep burn wounds with periosteal necrosis successfully treated by use of allogenic cultured dermal substitute.

Authors:  Naoki Ohara; Shoji Mihara; Hiroyuki Nihara; Narihiro Akimoto; Naoki Madokoro; Mikio Kawai; Hideki Noda; Michihiro Hide; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2010-03-27       Impact factor: 1.731

3.  Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

Authors:  David M Harris; Inbal Hazan-Haley; Kevin Coombes; Carlos Bueso-Ramos; Jie Liu; Zhiming Liu; Ping Li; Murali Ravoori; Lynne Abruzzo; Lin Han; Sheela Singh; Michael Sun; Vikas Kundra; Razelle Kurzrock; Zeev Estrov
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

4.  Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study.

Authors:  Giorgio Pajardi; Vicenzo Rapisarda; Francesco Somalvico; Andrea Scotti; Giulia Lo Russo; Francesco Ciancio; Arturo Sgrò; Manuela Nebuloni; Raffaele Allevi; Maria L Torre; Emilio Trabucchi; Mario Marazzi
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

5.  Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Authors:  Tomonori Taniguchi; Yasuyuki Amoh; Kenichi Tanabe; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-08-23       Impact factor: 1.731

6.  Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.

Authors:  Naoto Yamada; Eiju Uchinuma; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-12-03       Impact factor: 1.731

Review 7.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 8.  Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries.

Authors:  Álvaro Sierra-Sánchez; Kevin H Kim; Gonzalo Blasco-Morente; Salvador Arias-Santiago
Journal:  NPJ Regen Med       Date:  2021-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.